IP Verse

Compositions And Methods For Lowering Levels Of High-Sensitivity (Hs-Crp) In A Subject - EP2800469B1

PatentPatent Analysis

EP2800469

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP13733751A
Filing Date
Jan 7, 2013
Status
Revoked
Jan 27, 2023
Grant Date
Aug 25, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3815684B1
EP4056176B1
EP3318255B1

Bibliography

The patent EP2800469B1 was granted to Amarin Pharmaceuticals Ireland on Aug 25, 2021 following the initial filing on Jan 7, 2013 under the application number EP13733751A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

COOKEMay 25, 2022ADMISSIBLE
ELKINGTON AND FIFEMay 23, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents